About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avalon GloboCare Corp. - Common Stock (NQ:ALBT)

0.4122 -0.0078 (-1.86%)
Streaming Delayed Price Updated: 3:51 PM EDT, May 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avalon GloboCare Corp. - Common Stock

< Previous 1 2 3 Next >
News headline image
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
Via Benzinga
News headline image
What's Going On With Kala Pharmaceuticals Shares Today ↗
Kala Pharmaceutical (NASDAQ: KALA) shares skyrocketed more than 20% Monday morning on higher-than-average volume. On an average market day, Kala shares trade about 2.5 million times throughout the... 
Via Benzinga
News headline image
What's Going On With Avalon GloboCare Shares Today ↗
The overall market ticked slightly higher in pre-market trading Monday morning, but Avalon Globocare Corp (NASDAQ: ALBT) shares really took off. Avalon GloboCare is a biotech company headquartered in... 
Via Benzinga
News headline image
Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January ↗
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.24% to 33,471.14 while the NASDAQ rose... 
Via Benzinga
Avalon GloboCare Partnerships, Completed Capital Raise, And Robust IP Portfolio Expose An Attractive Value Proposition ($ALBT)
Via AB Newswire
With Multiple Shots On Revenue-Generating Goals, Avalon GloboCare Positions For A Breakout 2023 ($ALBT)
Via AB Newswire
Topics Intellectual Property
Avalon GloboCare Strengthens IP Portfolio, Earns Breakthrough Patent For QTY-Code Technology ($ALBT)
Via AB Newswire
Topics Intellectual Property
Avalon GloboCare Scores Patent For Breakthrough QTY-Code Technology To Expedite Developing Better Cancer Treatments ($ALBT)
Via AB Newswire
Topics Intellectual Property
News headline image
Kala Pharmaceuticals, PaxMedica, Getty And Other Short Squeeze Stocks That Could Soar ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
News headline image
Kala Pharmaceuticals, Getty Images And This Bitcoin Stock Top Short Squeeze Leaderboard: 10 Short Squeeze Stocks To Watch ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
Avalon GloboCare Stock Completes $4.0 Million Private Placement Priced At A Premium To Accelerate Closing Accretive Acquisition ($ALBT)
Via AB Newswire
Avalon GloboCare Stock Rallies On Acquisition, Partnership, And Clinical Program Updates ($ALBT)
Via AB Newswire
News headline image
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. 
Via Benzinga
Avalon GloboCare Shares Higher; Partnerships And Planned Acquisition Fuel Investor Interest ($ALBT)
Via AB Newswire
News headline image
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.